The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Dyslipidemia
Abstract
Dyslipidemia is an important risk factor for coronary artery disease and stroke. Long-term, prospective epidemiologic studies have consistently shown that persons with healthier lifestyles and fewer risk factors for coronary heart disease, and particularly those with favorable lipid profiles, have reduced incidence of coronary heart disease. Prevention and sensible management of dyslipidemia can markedly alter cardiovascular morbidity and mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., Darius, H., Lewis, B. S., Ophuis, T. O., Jukema, J. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410489 · Cited by 4,487
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
de Lorgeril, M., Salen, P., Martin, J.-L., Monjaud, I., Delaye, J., & Mamelle, N. (1999) · Circulation · doi:10.1161/01.cir.99.6.779 · Cited by 2,910
ADOLESCENTS, E. P. O. I. G. F. C. H. A. R. R. I. C. A. (2011) · Pediatrics · doi:10.1542/peds.2009-2107c · Cited by 2,585
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000366 · Cited by 2,466
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Robinson, J. G., Farnier, M., Krempf, M., Bergeron, J., Luc, G., Averna, M., Stroes, E. S., Langslet, G., Raal, F. J., El Shahawy, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501031 · Cited by 2,296
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801936 · Cited by 2,043
Effects of extended-release niacin with laropiprant in high-risk patients
The HPS2-THRIVE Collaborative Group (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1300955 · Cited by 1,668
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
Sabatine, M. S., Giugliano, R. P., Wiviott, S. D., Raal, F. J., Blom, D. J., Robinson, J., Ballantyne, C. M., Somaratne, R., Legg, J., Wasserman, S. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500858 · Cited by 1,509
Sarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., Boekholdt, S. M., Khaw, K.-T., & Gudnason, V. (2007) · Circulation · doi:10.1161/circulationaha.106.637793 · Cited by 1,408
Bruckert, E., Hayem, G., Dejager, S., Yau, C., & Bégaud, B. (2005) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-005-5686-z · Cited by 1,226
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Houston Miller, N., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.003 · Cited by 1,160
The safety of statins in clinical practice
Armitage, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60716-8 · Cited by 833
US Preventive Services Task Force, Grossman, D. C., Bibbins-Domingo, K., Curry, S. J., Barry, M. J., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., Krist, A. H., et al. (2017) · JAMA · doi:10.1001/jama.2017.6803 · Cited by 815
A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
Blom, D. J., Hala, T., Bolognese, M., Lillestol, M. J., Toth, P. D., Burgess, L., Ceska, R., Roth, E., Koren, M. J., Ballantyne, C. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1316222 · Cited by 720
Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
Stein, E. A., Mellis, S., Yancopoulos, G. D., Stahl, N., Logan, D., Smith, W. B., Lisbon, E., Gutierrez, M., Webb, C., Wu, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105803 · Cited by 664
Cholesterol and Mortality: 30 Years of Follow-up From the Framingham Study
Anderson, K. M. (1987) · JAMA · doi:10.1001/jama.1987.03390160062027 · Cited by 620
US Preventive Services Task Force (2010) · Pediatrics · doi:10.1542/peds.2009-2037 · Cited by 617
Langsted, A., Freiberg, J. J., & Nordestgaard, B. G. (2008) · Circulation · doi:10.1161/circulationaha.108.804146 · Cited by 588
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-5-201209040-00475 · Cited by 535
DeFilippis, A. P., Young, R., Carrubba, C. J., McEvoy, J. W., Budoff, M. J., Blumenthal, R. S., Kronmal, R. A., McClelland, R. L., Nasir, K., & Blaha, M. J. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1281 · Cited by 515
McKenney, J. M., Davidson, M. H., Jacobson, T. A., & Guyton, J. R. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.02.030 · Cited by 431
Nut Consumption and Blood Lipid Levels: A Pooled Analysis of 25 Intervention Trials
Sabaté, J. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.79 · Cited by 422
Navarese, E. P., Kołodziejczak, M., Schulze, V., Gurbel, P. A., Tantry, U., Lin, Y., Brockmeyer, M., Kandzari, D. E., Kubica, J. M., D'Agostino, R. B., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2957 · Cited by 404
Effects of Walnuts on Serum Lipid Levels and Blood Pressure in Normal Men
Sabate, J., Fraser, G. E., Burke, K., Knutsen, S. F., Bennett, H., & Lindsted, K. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303043280902 · Cited by 397
Dujovne, C. A., Ettinger, M. P., McNeer, J. F., Lipka, L. J., LeBeaut, A. P., Suresh, R., Yang, B. O., & Veltri, E. P. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02798-4 · Cited by 391
Fasting Time and Lipid Levels in a Community-Based Population: A Cross-sectional Study
Sidhu, D., & Naugler, C. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.3708 · Cited by 293
Kuvin, J. T., Rämet, M. E., Patel, A. R., Pandian, N. G., Mendelsohn, M. E., & Karas, R. H. (2002) · American Heart Journal · doi:10.1067/mhj.2002.123145 · Cited by 233
Finegold, J. A., Manisty, C. H., Goldacre, B., Barron, A. J., & Francis, D. P. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314525531 · Cited by 214
Effects of plant-based diets on plasma lipids
Ferdowsian, H. R., & Barnard, N. D. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.05.032 · Cited by 196
Selvarajah, S., Kaur, G., Haniff, J., Cheong, K. C., Hiong, T. G., van der Graaf, Y., & Bots, M. L. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.07.066 · Cited by 188
Gencer, B., Kronenberg, F., Stroes, E. S., & Mach, F. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx033 · Cited by 184
Statin Therapy for Primary Prevention of Cardiovascular Disease
Taylor, F. C., Huffman, M. D., & Ebrahim, S. B. J. (2013) · JAMA · doi:10.1001/jama.2013.281348 · Cited by 161
Craig, S. R., Amin, R. V., Russell, D. W., & Paradise, N. F. (2000) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2000.03509.x · Cited by 132
Rodriguez-Colon, S. M., Mo, J., Duan, Y., Liu, J., Caulfield, J. E., Jin, X., & Liao, D. (2008) · Stroke · doi:10.1161/strokeaha.108.523035 · Cited by 112
Ernst, N. D., Sempos, C., Briefel, R., & Clark, M. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/66.4.965s · Cited by 104
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-5-201209040-00486 · Cited by 92
Wild, S. H., Byrne, C. D., Tzoulaki, I., Lee, A. J., Rumley, A., Lowe, G. D. O., & Fowkes, F. G. R. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.028 · Cited by 57
Cleeman, J. I., & Grundy, S. M. (1997) · Circulation · doi:10.1161/01.cir.95.6.1646 · Cited by 52
Cholesterol and coronary heart disease mortality. A 23-year follow-up study of 9902 men in Israel.
Goldbourt, U., & Yaari, S. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.4.512 · Cited by 50
The Emerging Role of Lipoproteins in Atherogenesis: Beyond LDL Cholesterol
Nicholls, S. J., & Lundman, P. (2004) · Seminars in Vascular Medicine · doi:10.1055/s-2004-835377 · Cited by 49
Achieving Optimal Lipid Goals in Patients With Coronary Artery Disease
Karalis, D. G., Subramanya, R. D., Hessen, S. E., Liu, L., & Victor, M. F. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.11.006 · Cited by 44
Cited by
Exploring and comparing adverse events between PARP inhibitors
LaFargue, C. J., Dal Molin, G. Z., Sood, A. K., & Coleman, R. L. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30786-1 · Cited by 487
Roles and mechanisms of exosomal non-coding RNAs in human health and diseases
Li, C., Ni, Y.-Q., Xu, H., Xiang, Q.-Y., Zhao, Y., Zhan, J.-K., He, J.-Y., Li, S., & Liu, Y.-S. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00779-x · Cited by 406
Relationship between Hyperlipidemia, Cardiovascular Disease and Stroke: A Systematic Review
Alloubani, A., Nimer, R., & Samara, R. (2021) · Current Cardiology Reviews · doi:10.2174/1573403x16999201210200342 · Cited by 314
Sharifi-Rad, J., Rodrigues, C. F., Sharopov, F., Docea, A. O., Can Karaca, A., Sharifi-Rad, M., Kahveci Karıncaoglu, D., Gülseren, G., Şenol, E., Demircan, E., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17072326 · Cited by 285
High Remnant Cholesterol Level Potentiates the Development of Hypertension
Chen, M.-M., Huang, X., Xu, C., Song, X.-H., Liu, Y.-M., Yao, D., Lu, H., Wang, G., Zhang, G.-L., Chen, Z., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.830347 · Cited by 78
Metadata
- Authors
- Kopin, L., & Lowenstein, C. J.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2017-12-05
- Volume
- 167
- Issue
- 11
- Pages
- ITC81-ITC96
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W4233762426
- Cited by
- 582
- References
- 45
- FWCI
- 16.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.